Teleflex (NYSE:TFX – Get Free Report) and NeuroPace (NASDAQ:NPCE – Get Free Report) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, profitability, earnings and valuation. Insider and Institutional Ownership 97.2% of Teleflex shares are owned […]
Teleflex (NYSE:TFX – Get Free Report) and Sector 10 (OTCMKTS:SECI – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, earnings, analyst recommendations, valuation and profitability. Valuation and Earnings This table compares Teleflex and Sector […]
StockNews.com lowered shares of Teleflex (NYSE:TFX – Free Report) from a buy rating to a hold rating in a research note released on Thursday. A number of other equities analysts have also recently issued reports on the stock. Truist Financial upped their price objective on shares of Teleflex from $210.00 to $221.00 and gave the […]
Osterweis Capital Management Inc. boosted its holdings in Teleflex Incorporated (NYSE:TFX – Free Report) by 11.8% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 73,840 shares of the medical technology company’s stock after buying an additional 7,764 shares during the quarter. Osterweis Capital Management […]
Teleflex stock (NYSE: TFX), which provides instruments and consumables for laboratories, trades at $220 per share, 50% below the level seen in March 2021.